The Fred Hutchinson Cancer Research Center is an independent, non-profit research center, incorporated in 1971 and established exclusively for cancer research. The Center is organized into five divisions: the three scientific Divisions of Basic Sciences, Clinical Research and Public Health Sciences, and the Administration and Development divisions. Scientific programs include: Basic Sciences - Biochemical Oncology, Cell Biology, Developmental Biologiy, Genetics, Molecular Biology and Immunology, Molecular Medicine (interdisciplinary), Tumor Biology and Viral Oncology. Clinical Research - Allogeneic Marrow Transplant for Malignant Disease, Autologous Marrow Transplantation, Biological Response Modifiers, Chemoimmunotherapy and Syngenic Marrow Transplantation, Experimental Pathology (interdisciplinary), Human Immunogenetics, Infectious Diseases, Pain & Toxicity Research, Pediatric Oncology, Clinical Pathology, Supportive Care and Transplantation Biology. Public Health Sciences - Biostatistics, Epidemiology and Cancer Prevention. Newly developing programs included in this proposal are Gastroenterology and Nutrition Research. This application requests renewal of the Center's existing Caner Center Support Grant (Comprehensive). Support requested will continue the development and maintenance of support for professional personnel (Senior Leadership, Major Program Heads, and Staff Investigators), division administration and planning, shared resources and development of the new programs mentioned above.

Agency
National Institute of Health (NIH)
Institute
National Cancer Institute (NCI)
Type
Center Core Grants (P30)
Project #
2P30CA015704-15
Application #
3101476
Study Section
Cancer Center Support Grant Review Committee (CCS)
Project Start
1977-01-01
Project End
1993-01-31
Budget Start
1988-03-01
Budget End
1989-01-31
Support Year
15
Fiscal Year
1988
Total Cost
Indirect Cost
Name
Fred Hutchinson Cancer Research Center
Department
Type
DUNS #
075524595
City
Seattle
State
WA
Country
United States
Zip Code
98109
Georges, George E; Doney, Kris; Storb, Rainer (2018) Severe aplastic anemia: allogeneic bone marrow transplantation as first-line treatment. Blood Adv 2:2020-2028
Duggan, Catherine; Tapsoba, Jean de Dieu; Stanczyk, Frank et al. (2018) Long-term weight loss maintenance, sex steroid hormones, and sex hormone-binding globulin. Menopause :
Yu, Ming; Maden, Sean K; Stachler, Matthew et al. (2018) Subtypes of Barrett's oesophagus and oesophageal adenocarcinoma based on genome-wide methylation analysis. Gut :
Lam, Hung-Ming; Corey, Eva (2018) Supraphysiological Testosterone Therapy as Treatment for Castration-Resistant Prostate Cancer. Front Oncol 8:167
Fowler, Kyle R; Hyppa, Randy W; Cromie, Gareth A et al. (2018) Physical basis for long-distance communication along meiotic chromosomes. Proc Natl Acad Sci U S A 115:E9333-E9342
Ogimi, Chikara; Xie, Hu; Leisenring, Wendy M et al. (2018) Initial High Viral Load Is Associated with Prolonged Shedding of Human Rhinovirus in Allogeneic Hematopoietic Cell Transplant Recipients. Biol Blood Marrow Transplant 24:2160-2163
Jeong, Kyoung Sook; Zhou, Jin; Griffin, Stephanie C et al. (2018) MicroRNA Changes in Firefighters. J Occup Environ Med 60:469-474
Appelbaum, Jacob; Wells, David; Hiatt, Joseph B et al. (2018) Fatal enteric plexus neuropathy after one dose of ipilimumab plus nivolumab: a case report. J Immunother Cancer 6:82
Blair, Kris M; Mears, Kevin S; Taylor, Jennifer A et al. (2018) The Helicobacter pylori cell shape promoting protein Csd5 interacts with the cell wall, MurF, and the bacterial cytoskeleton. Mol Microbiol 110:114-127
Talarico, Sarah; Korson, Andrew S; Leverich, Christina K et al. (2018) High prevalence of Helicobacter pylori clarithromycin resistance mutations among Seattle patients measured by droplet digital PCR. Helicobacter 23:e12472

Showing the most recent 10 out of 1267 publications